• No results found

ACEI, angiotensin-converting enzyme inhibitor

Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study

Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study

... ratio; ACEI: Angiotensinconverting enzyme inhibitor; ARB: Angiotensin receptor blocker; ASCVD: Atherosclerotic cardio‑ vascular disease; CAC : Coronary artery calcification; ...

10

Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome

Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome

... Abbreviations: ACeI, angiotensin-converting enzyme inhibitor; ACs, acute coronary syndrome; ArB, angiotensin receptor blocker; BMI, body mass index; CABg, coronary artery bypass ...

8

The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

... ACEI: angiotensinconverting enzyme inhibitor; ACS: acute coronary syn‑ drome; AMI: acute myocardial infarction; ARB: angiotensin receptor blocker; CAROLINA: cardiovascular ...

11

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity

... dimensional; ACEI: Angiotensin-converting enzyme inhibitor; AIC: Anthracycline-induced cardiotoxicity; ARB: Angiotensin receptor blocker; ASCO: American Society of Clinical ...

7

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease

... ACEI: Angiotensin-converting enzyme inhibitor; ADPKD: Autosomal dominant polycystic kidney disease; ARB: Angiotensin receptor blocker; CDSR: Cochrane database of systematic ...

16

Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty

Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty

... ACEi: Angiotensin-converting enzyme inhibitor; ANOVA: Analysis of variance; ARAS: Atherosclerotic renal artery stenosis; ARB: Angiotensin type 1 receptor blocker; ASTRAL: The ...

9

High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes

High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes

... ACEI: angiotensin-converting enzyme inhibitor; ACR: albumin-to-creatinine ratio; ALT: alanine aminotransferase; ARB: angiotensin receptor blocker; AST: asparatate ...

7

Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials

Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials

... ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CI: Confidence interval; CKD: Chronic kidney disease; CPGs: Clinical practice guidelines; ESKD: ...

14

Hypertension and blood pressure variability management practices among physicians in Singapore

Hypertension and blood pressure variability management practices among physicians in Singapore

... monitoring; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta-blocker; BP, blood pressure; BPV, BP variability; CCB, calcium channel ...

11

Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial

Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial

... ACEI: Angiotensin-converting enzyme inhibitor; ACR: Albumin-to-creatinine ratio; AE: Adverse event; ARB: Angiotensin II receptor blocker; CHM: Chinese herbal medicine; CKD: ...

8

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial

... DOC 121 kb Abbreviations ACEi: Angiotensin-converting enzyme inhibitor; ADMA: Asymmetric dimethylarginine; AER: Albumin excretion rate; ARB: Angiotensin receptor blocker; BTE: Black tea [r] ...

9

Acute kidney injury after cardiac arrest

Acute kidney injury after cardiac arrest

... ACEI: angiotensin-converting enzyme inhibitor; AKI: acute kidney injury; ARB: angiotensin II receptor blocker; ARC: augmented renal clearance; BAL: bronchoalveolar lavage; CA: ...

12

Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL 2 Study): study protocol for a randomised controlled trial

Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL 2 Study): study protocol for a randomised controlled trial

... ACE: Angiotensin converting enzyme; ACEI: Angiotensin converting enzyme inhibitor; ACR: Albumin-creatinine ratio; ARB: Angiotensin receptor blocker; CKD: ...

10

Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study

Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study

... ACE: Angiotensin converting enzyme; ACEi: Angiotensin-converting enzyme inhibitor; AGT: Angiotensinogen; ARB: Angiotensin-II receptor blocker; BMI: Body mass ...

12

The SEISICAT study: a pilot study assessing 1 efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy

The SEISICAT study: a pilot study assessing 1 efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy

... in cats with congestive heart failure secondary to cardiomyopathy being treated in.. combination with furosemide and an angiotensin converting enzyme inhibitor ACEi...[r] ...

45

Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy

Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy

... ACEI/ARB: angiotensin converting enzyme inhibitor/angiotensin receptor blocker; ACS: acute coronary syndrome; AF: atrial fibrillation; ATE: arterial thromboembolic event; ATRIA: ...

11

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan

<p>Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan</p>

... of angiotensin receptor-neprilysin inhibitor (ARNI) therapy in the heart failure (HF) treatment paradigm through examination of the trial population characteristics and the mortality bene fi t observed in ...

11

Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial

Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial

... Methods: Leucine and ACE inhibitors in sarcopenia (LACE) is a multicentre, masked, placebo-controlled, 2 × 2 factorial randomised trial evaluating the efficacy of leucine and perindopril (angiotensin ...

11

Design, Synthesis, Docking Study and Antiplatelet Evaluation of New Thiosemicarbazide Derivatives Derived from Captopril

Design, Synthesis, Docking Study and Antiplatelet Evaluation of New Thiosemicarbazide Derivatives Derived from Captopril

... active angiotensin converting enzyme inhibitor (ACEI) drug, containing thiosemicarbazide moiety, for enhancing the cardiovascular activity of captopril, and avoid the main limitations ...

10

Angioedema in the emergency department: a practical guide to differential diagnosis and management

Angioedema in the emergency department: a practical guide to differential diagnosis and management

... esterase inhibitor (C1-INH), side effects of angiotensin-converting enzyme inhibitors (ACEis), or acquired deficiency in ...with ACEi-induced angioedema in the ED; however, surveys have ...

11

Show all 10000 documents...

Related subjects